A Knock-In Igfn1iCre transgenic mouse line provides partial developmental access to type-7 bipolar cells

Key Points

• The aim is to develop and utilize a knock-in Igfn1iCre transgenic mouse line for studying type-7 bipolar cells in the retina.
• Creation of a knock-in Igfn1iCre transgenic mouse line.
• Assessment of developmental access to type-7 bipolar cells in the retina.
• The transgenic mouse line allows for partial access to type-7 bipolar cells during development.
• Demonstrated potential as a tool for further research on retinal cells.